Cargando…
Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience
Key objectives in the treatment of multiple sclerosis (MS) include prevention of relapses, a reduction in the accumulation of disability and slowing of the brain volume loss that occurs from the earliest stages of the disease. Teriflunomide, a once-daily, oral immunomodulatory therapy, has demonstra...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703103/ https://www.ncbi.nlm.nih.gov/pubmed/29204190 http://dx.doi.org/10.1177/1756285617722500 |